Bluejay Diagnostics Inc (BJDX)

Jun 3, 2025, 4:05 PM EDT - 2 days ago

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Apr 15, 2025, 7:00 AM EDT - 7 weeks ago

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Apr 7, 2025, 5:21 PM EDT - 2 months ago

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Nov 13, 2024, 5:10 PM EST - 7 months ago

Bluejay Diagnostics Announces Reverse Stock Split

Jun 28, 2024, 11:32 AM EDT - 1 year ago

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

Jun 26, 2024, 8:00 AM EDT - 1 year ago

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Jan 2, 2024, 5:58 PM EST - 1 year ago

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Dec 28, 2023, 8:00 AM EST - 1 year ago

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Dec 27, 2023, 9:00 AM EST - 1 year ago

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Nov 9, 2023, 4:05 PM EST - 1 year ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Aug 25, 2023, 8:00 AM EDT - 1 year ago

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aug 16, 2023, 7:00 AM EDT - 1 year ago

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

May 19, 2023, 7:00 AM EDT - 2 years ago

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

May 10, 2023, 7:30 AM EDT - 2 years ago

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

Mar 20, 2023, 4:15 PM EDT - 2 years ago

Bluejay Diagnostics Reports 2022 Financial Results

Feb 16, 2023, 8:00 AM EST - 2 years ago

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Nov 9, 2022, 8:00 AM EST - 2 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Sep 8, 2022, 9:33 AM EDT - 2 years ago

Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

BSGM STSS

Aug 30, 2022, 4:05 PM EDT - 3 years ago

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Aug 16, 2022, 7:30 AM EDT - 3 years ago

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Jul 27, 2022, 7:30 AM EDT - 3 years ago

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Jul 26, 2022, 4:30 PM EDT - 3 years ago

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Jul 6, 2022, 7:30 AM EDT - 3 years ago

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Jun 9, 2022, 10:19 AM EDT - 3 years ago

Why Bluejay Diagnostics Shares Are Surging Higher Today

Apr 20, 2022, 4:10 PM EDT - 3 years ago

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Mar 28, 2022, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Mar 24, 2022, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Mar 10, 2022, 7:00 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Jan 31, 2022, 7:00 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Jan 13, 2022, 11:29 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Jan 5, 2022, 8:15 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Dec 16, 2021, 9:11 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Nov 10, 2021, 8:15 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering